Mar 11, 2025 | Drug costs, GLP-1s, Health care costs, Ozempic, Pharmacy, Rx Costs, Wegovy, Weight loss, Weight loss drugs, Zepbound
The end of shortages on Ozempic, Wegovy, and other semaglutide injections could place added pressure on self-funded health plans to cover the costs of the high-priced medications. On February 21, the FDA confirmed that the supply of GLP-1 drugs used to treat obesity...
Feb 10, 2025 | Chronic conditions, Cost Savings, Drug costs, Flexible spending accounts (FSAs), Health care costs, MedBen Rx, Pharmacogenomics, Rx Costs, Savings
Now available through MedBen Rx, pharmacogenomic testing is transforming health care through safer and more effective personalized medicine. Determining how genes affect a person’s response to drugs not only improves patient outcomes, but it also helps control...
Dec 30, 2024 | Cost Savings, Direct-to-Employer Contracting, Formularies, Health care costs, Networks, Pharmacy Benefits Manager (PBM), Research
A recent “Pulse of the Purchaser” survey offers interesting insights about strategies employers are using to successfully lower their medical and pharmacy costs… strategies that, not surprisingly, have long been in use by many MedBen clients. Among...
Nov 26, 2024 | Alternative Reimbursement Strategies, Case Studies, Cost Savings, Direct-to-Employer Contracting, Health care costs, Savings
From Benefits Pro: “According to the 2024 Best Practices in Healthcare Survey from WTW, more than half of employers plan to implement programs that will reduce total costs, and just as many intend to adopt plan design and network strategies that steer workers to...
Oct 29, 2024 | Alternative Reimbursement Strategies, Chronic conditions, Client Report, Cost projections, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair market reimbursement, Forensic claims review, Health care costs, High-cost claims, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Transparency, Trend, Wellness
Health care costs in the United States are projected to see their steepest rise in over a decade during 2025, with multiple industry analyses forecasting increases between 7% and 8% year-over-year (see table below). However, MedBen offers solutions that directly...
Sep 13, 2024 | Cancer, Health care costs, Heart disease, High-cost claims, Mental Health, Rx Costs, Survey
Employers say they expect their health care costs to rise 7.8% next year — the highest estimate in more than 15 years — according to the latest Business Group on Health member survey. Even factoring in cost-reducing plan design changes, respondents project costs to...
